Héctor Eliud Arriaga-Cázares

Dr. Héctor Eliud Arriaga-Cázares

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2014 in Cell Cycle
Verified
Journal Article
Open access
SCShuyuan Chen
Shuyuan Chen
RBRaul Bastarrachea
Raul Bastarrachea
BRBrad J Roberts
Brad J Roberts
VVV Saroja Voruganti
V Saroja Voruganti
PFPatrice A Frost
Patrice A Frost
PGPaul A Grayburn
Paul A Grayburn
Both major forms of diabetes mellitus (DM) involve β-cell destruction and dysfunction. New treatment strategies have focused on replenishing the deficiency of β-cell mass common to both major forms of diabetes by islet transplantation or β-cell regeneration. The pancreas, not the liver, is the ideal organ for islet regeneration, because it is the natural milieu for islets. Since islet mass is known to increase during obesity and pregnancy, the concept of stimulating pancreatic islet regeneration in vivo is both rational and physiologic. This paper proposes a novel approach in which non-viral gene therapy is targeted to pancreatic islets using ultrasound targeted microbubble destruction (UTMD) in a non-human primate model (NHP), the baboon. Treated baboons received a gene cocktail comprised of cyclinD2, CDK, and GLP1, which in rats results in robust and durable islet regeneration with normalization of blood glucose, insulin, and C-peptide levels. We were able to generate important preliminary data indicati...

1 January 2021 in Journal of Clinical Lipidology
Verified
Journal Article
Open access
RMRoopa Mehta
Roopa Mehta
AMAlexandro J. Martagon
Alexandro J. Martagon
GRGabriela A. Galan Ramirez
Gabriela A. Galan Ramirez
NANeftali Eduardo Antonio-Villa
Neftali Eduardo Antonio-Villa
AVArsenio Vargas-Vázquez
Arsenio Vargas-Vázquez
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
Familial hypercholesterolemia (FH) remains underdiagnosed and undertreated. Report the results of the first years (2017-2019) of the Mexican FH registry. There are 60 investigators, representing 28 federal states, participating in the registry. The variables included are in accordance with the European Atherosclerosis Society (EAS) FH recommendations. To date, 709 patients have been registered, only 336 patients with complete data fields are presented. The mean age is 50 (36-62) years and the average time since diagnosis is 4 (IQR: 2-16) years. Genetic testing is recorded in 26.9%. Tendon xanthomas are present in 43.2%. The prevalence of type 2 diabetes is 11.3% and that of premature CAD is 9.8%. Index cases, male gender, hypertension and smoking were associated with premature CAD. The median lipoprotein (a) level is 30.5 (IQR 10.8-80.7) mg/dl. Statins and co-administration with ezetimibe were recorded in 88.1% and 35.7% respectively. A combined treatment target (50% reduction in LDL-C and an LDL-C <100 mg/dl) was achieved by 13.7%. Associated factors were index case (OR 3.6, 95%CI 1.69-8.73, P = .002), combination therapy (OR 2.4, 95%CI 1.23-4.90, P = .011), type 2 diabetes (OR 2.8, 95%CI 1.03-7.59, P = .036) and age (OR 1.023, 95%CI 1.01-1.05, P = .033). The results confirm late diagnosis, a lower than expected prevalence and risk of ASCVD, a higher than expected prevalence of type 2 diabetes and undertreatment, with relatively few patients reaching goals. Recommendations include, the use of combination lipid lowering therapy, control of comorbid conditions and more frequent genetic testing in the future.

30 June 2015 in Journal of Medical Primatology
Verified
Journal Article
Closed access
PDF file
PFPatrice A. Frost
Patrice A. Frost
SCShuyuan Chen
Shuyuan Chen
MMMarguerite J. Mezzles
Marguerite J. Mezzles
VVVenkata Saroja Voruganti
Venkata Saroja Voruganti
ENEdna J. Nava‐Gonzalez
Edna J. Nava‐Gonzalez
RBRaul Bastarrachea
Raul Bastarrachea

8 January 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
HAHéctor Eliud Arriaga-Cázares
Héctor Eliud Arriaga-Cázares
DVDavid Vega-Morales
David Vega-Morales
CMCarlos Alberto Moreno-Treviño
Carlos Alberto Moreno-Treviño
JJJuana Lorena Juarez-Juarez
Juana Lorena Juarez-Juarez
CPCarlos Azael Pérez-Arizmendi
Carlos Azael Pérez-Arizmendi
AMAlexandro Martagón
Alexandro Martagón
Background: Childhood dyslipidemia is a common condition that can lead to atherosclerotic cardiovascular disease in adulthood. It is usually multifactorial. Screening for cholesterol disorders in children varies based on risk factors, with some guidelines recommending cascade screening for children with a clear family history of familial hypercholesterolemia, targeted screening for those with specific risk factors, and universal screening. Point-of-care testing (POCT) cholesterol tests offer potential advantages, including ease of use, portability, increased patient access, low cost, fewer medical or laboratory visits, and instant results. This study aimed to evaluate the effect of POCT cholesterol screening on the diagnosis of hypercholesterolemia in children in a family practice setting. Methods: We used a POCT cholesterol analyzer to perform two different (universal and targeted) screening approaches for dyslipidemia in children. We used the NCEP guidelines for the classification of the results. Results: We screened 183 children, 105 in the universal screening group and 78 in the targeted screening group. Eight patients in the targeted screening group had elevated cholesterol levels (p = 0.02). Conclusions: All participants received instant feedback and recommendations. Using a targeted screening approach, POCT could be a practical and effective tool for identifying at-risk children with hypercholesterolemia.

5 July 2024 in Cureus
Verified
Journal Article
Open access
PDF file
HAHéctor Eliud Arriaga-Cázares
Héctor Eliud Arriaga-Cázares
JRJose Pablo Rodriguez-Lopez
Jose Pablo Rodriguez-Lopez
FAFernando Ancira-Gonzalez
Fernando Ancira-Gonzalez
SCSergio Charles-Lozoya
Sergio Charles-Lozoya
Background Hip fracture patients often experience surgical site infections (SSIs) as a major infectious complication after undergoing total hip arthroplasty (THA), which can lead to extended hospital stays, increased mortality, and higher healthcare costs. This study aimed to determine the incidence of SSI and identify the risk factors associated with it after THA. Objective This study aimed to explore the correlation between blood transfusion along with other factors and the occurrence of SSIs in postoperative patients who underwent THA for transcervical femoral neck fractures. Methods We conducted a retrospective analysis by reviewing the medical records of patients aged 60-80 years who underwent surgery for hip fractures at the Unidad Médica de Alta Especialidad Hospital de Traumatología y Ortopedia No. 21 in Monterrey, Mexico, between January 2020 and January 2021. We analyzed potential risk factors such as age, sex, transfusion necessity, preoperative hemoglobin levels, history of diabetes mellitus, arterial hypertension, and end-stage chronic disease. Data are presented as numbers and percentages, and statistical analyses were performed using IBM SPSS Statistics for Windows, Version 28.0 (Released 2021; IBM Corp., Armonk, New York, United States). Results The study included 87 patients, of whom 55 (63%) were women with an average age of 73 years. SSIs were identified in 12 (13.8%) patients. Among those with infections, nine (75%) had a history of blood transfusion (p=0.05). Diabetes, hypertension, and chronic kidney disease also increased the risk for infection. There was no association with gender, age, American Society of Anesthesiologists (ASA) risk, and preoperative hemoglobin. Conclusions We found a heightened risk of SSI in patients with a history of blood transfusions, emphasizing the need for careful consideration and monitoring during the perioperative period. Additionally, patients with comorbidities such as diabetes, hypertension, and chronic kidney disease were more susceptible to SSI, underscoring the importance of preoperative assessment and targeted preventive measures. Further research and collaboration are needed to refine strategies for mitigating SSI risk factors and optimizing healthcare resource utilization.

14 November 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SCSergio Charles-Lozoya
Sergio Charles-Lozoya
ELEduardo López-Galindo
Eduardo López-Galindo
HCHector Cobos
Hector Cobos
EMEdgar Manilla-Muñoz
Edgar Manilla-Muñoz
MPMiguel Leonardo de la Parra-Márquez
Miguel Leonardo de la Parra-Márquez
NDNancy Elena Guzman Delgado
Nancy Elena Guzman Delgado
Background: Minimally invasive plate osteosynthesis (MIPO) for humeral diaphyseal fractures could result in better outcomes than open reduction and internal fixation (ORIF). However, the relationship between operative time, postoperative pain, and functional outcomes with respect to the use of standard dynamic compression plates (DCP) remains unclear. Therefore, this study aimed to evaluate the correlation between surgical duration, postoperative pain, and functional outcomes. Methods: A cohort case series of 28 patients with humeral shaft fractures was grouped into 12A1–12C3. MIPO and ORIF were performed in 13 and 15 patients, respectively. The study assessed demographic, surgical, complications, surgery duration (min), and pain levels 24 h postoperatively. Outcomes were measured using the UCLA shoulder rating score and Mayo Elbow Performance Score (MEPS). Bone union was assessed using the Radiographic Union Score for Humeral Fractures and bone bridges. Propensity score matching (PSM) was used to adjust for the covariates. Spearman’s test assessed correlations. Results: Twenty-eight patients and 13 matches ( n = 26) were analyzed after PSM. 24 h pain levels were compared between groups (MIPO 4 vs. ORIF 6, P = 0.04). The MIPO group exhibited an inverse correlation between pain and UCLA scores at 3 months (Rho = − 0.48; P = 0.02). UCLA scores revealed differences at 3, 6, and 24 months (MIPO 29, 35, 35 vs. 25, 33, 34 for ORIF) ( P = 0.01, 0.03, and 0.03, respectively). Intragroup UCLA assessments in both groups were ( P < 0.001). MEPS demonstrated no differences within or between groups. Conclusions: UCLA assessment at 3 months in both groups manifests a weak inverse correlation with postoperative pain. MIPO could be associated with reduced operative time, blood loss, and pain. It may lead to expedited functionality recovery, less radial nerve lesions, and pseudarthrosis when using DCP, which may be beneficial in resource-limited hospitals with a high patient’s demand.